Searchable abstracts of presentations at key conferences in endocrinology

ea0092op-11-03 | Oral Session 11: Autoimmunity / Hyperthyroidism | ETA2023

Effects of acute triiodothyronine treatment in patients with anterior myocardial infarction undergoing primary angioplasty: does infarct size matter?

Pantos Constantinos , Grigoriou Konstantinos , Trikas Athanasios , Pissimisis Evangelos , Stougiannos Pavlos , Dimopoulos Antonios , Linardakis Sarantos , Alexopoulos Nikolaos , Evdoridis Costas , Gavrielatos Gerasimos , Patsourakos Nikolaos , Papakonstantinou Nikolaos , Theodosis-Georgilas Anastasios , Mourouzis Iordanis

Objectives: Triiodothyronine (LT3) administration for 48hours in patients undergone primary angioplasty showed favourable effects on cardiac function and remodelling early after myocardial infarction (Thy-Repair, EudraCT 2016-000631-40, Thyroid 2022 Jun;32(6):714-724). The present study investigated whether this beneficial effect was dependent on the severity of infarct size. The extent of infarct size is one of the main determinants of morbidity and mortality after myocardial...